Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Path...

FDA Drug Recall #D-1516-2014 — Class III — July 30, 2014

Recall Summary

Recall Number D-1516-2014
Classification Class III — Low risk
Date Initiated July 30, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Novartis Pharmaceuticals Corp.
Location Suffern, NY
Product Type Drugs
Quantity 50 bottles

Product Description

Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.

Reason for Recall

Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.

Distribution Pattern

Nationwide

Lot / Code Information

Lot # PKTS, Exp 01/17

Other Recalls from Novartis Pharmaceuticals Corp.

Recall # Classification Product Date
D-1174-2023 Class I SANDIMMUNE Oral Solution (cyclosporine oral sol... Sep 8, 2023
D-1309-2019 Class I Promacta (eltrombopag) 12.5 mg for Oral Suspens... May 11, 2019
D-0678-2017 Class III Isopto Carpine (pilocarpine hydrochloride optha... Mar 22, 2017
D-0679-2017 Class III Pilocarpine Hydrochloride Ophthalmic Solution 4... Mar 22, 2017
D-1430-2015 Class III Dexmethylphenidate HCl Extended-Release, Capsul... Jul 28, 2015

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.